NLRP3 and COVID-19: It was reported that the NLRP3 inflammasome was over-activated in elderly patients with COVID-19, which could be attributable to defects in mitochondrial functioning, enhanced production of mitochondrial ROS (mtROS) and massive release of mitochondrial DNA (mtDNA) (137).